Also, the tumor penetrance in dbh: ALKF1174F mice is less efficient with 40% of the mice having neuroblastoma at 50 weeks of age, compared to Th-MYCN transgenic mice (Weiss et al., 1997; Rasmuson et al., 2012). Here, MYCN is linked to neoplasm.